ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced the closing of a $20 million Series A financing. Proceeds will be used to advance the company's lead program into Phase 2 clinical development for obesity and diabetes, as well as other programs in IND-enabling […]

Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes GlobeNewswire December 19, 2025 ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced the closing of a $20 million Series A

(NASDAQ:NVA),(NASDAQ:NVAWW),(OTC US:NVAAF),(Other OTC:NVAAF),(Boerse Frankfurt – Freiverkehr:QM3),(AUST:NVA.AX), Melbourne, Australia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company“) (Nasdaq NVA, NVAWW) (ASX: NVA)(FRA: QM3)), a gold, antimony and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, today announced the pricing of an underwritten

Nova Minerals Announces Pricing of Public Offering GlobeNewswire December 19, 2025 Melbourne, Australia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company“) (Nasdaq NVA, NVAWW) (ASX: NVA)(FRA: QM3)), a gold, antimony and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, today announced

AUSTIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — The science of the oral microbiome has moved from academic journals into mainstream health conversations, prompting growing consumer interest in understanding how bacterial balance may influence dental wellness. Against this backdrop, products like Synadentix, a chewable dental health supplement, have entered the market with formulas designed to support

Synadentix Targets Oral Microbiome as Consumers Seek Solutions Beyond Brushing for Gum Health and Fresh Breath Chewable nighttime formula featuring hydroxyapatite, lactoferrin, and enzyme complex enters dental supplement market amid rising interest in bacterial-balance approaches to oral care GlobeNewswire December 19, 2025 AUSTIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — The science of the oral microbiome

Sacramento, Dec. 18, 2025 (GLOBE NEWSWIRE) — With the New Year fast approaching and consumer interest in weight loss solutions historically peaking in December and January, SkinnyRx is positioning its telehealth platform to meet anticipated demand for GLP-1 medication access. The Sacramento-based company, operated by Lean Rx, Inc., offers compounded semaglutide and tirzepatide in three

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (NYSE:LRN) securities. If you suffered a loss on your Stride investment and would like to explore a potential recovery

Is SkinnyRx the Best GLP-1 Vendor for 2026? Platform Offers Compounded Semaglutide in Three Forms Starting at $199/Month as New Year Weight Loss Season Approaches Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of Peak January Demand Period GlobeNewswire December 19, 2025 Sacramento, Dec. 18, 2025 (GLOBE NEWSWIRE) — With

SCOTTSDALE, Dec. 18, 2025 (GLOBE NEWSWIRE) — DISCLAIMER: This content contains affiliate links. Compensation may be earned if readers choose to purchase the product mentioned through links provided. This press release is for informational purposes only and does not constitute medical advice. Individuals should consult qualified healthcare professionals before starting any dietary supplement. The statements